At the single variant level, we identified a novel missense variant in TERT with a striking degree of protection (carriers have a 7.5-times lower odds compared to non-carriers of developing prostate cancer), providing further evidence that telomere maintenance plays a key role in prostate cancer development. The gene discussed is TERT; the disease is prostate carcinoma.